UCLA Neurologist Dr. Rhonda Voskuhl Featured in Oprah Winfrey’s Groundbreaking Special, “The Menopause Revolution” | CleopatraRX

UCLA Neurologist Dr. Rhonda Voskuhl Featured in Oprah Winfrey’s Groundbreaking Special, “The Menopause Revolution”Von Greer2025-05-21T21:38:01+00:00

UCLA Neurologist Dr. Rhonda Voskuhl Featured in Oprah Winfrey’s Groundbreaking Special, “The Menopause Revolution”

March 31, 2025

Dr. Rhonda Voskuhl, Professor of Neurology at the University of California, Los Angeles (UCLA), and a leading expert in women’s brain health, was prominently featured in An Oprah Winfrey Special: The Menopause Revolution, which aired on ABC on March 31, 2025, and is now streaming on Hulu and Disney+. The primetime special, hosted by Oprah Winfrey, brought together renowned medical experts, celebrities, and leading voices to address the often-overlooked challenges of menopause, offering women vital insights and solutions to navigate this transformative life stage.

Dr. Voskuhl, the faculty neurologist for the UCLA Comprehensive Menopause Care Program and Director of the UCLA Multiple Sclerosis Program, shared her pioneering research on the impact of menopause on brain health. Highlighting the cognitive challenges many women face, such as memory lapses and difficulty maintaining focus, she emphasized the neuroprotective role of estrogen. “Not remembering why you walked into a room or losing verbal memory can interfere with jobs and confidence,” Dr. Voskuhl explained during the special. She discussed her innovative work with estriol, a form of estrogen that offers cognitive benefits with a lower risk profile compared to traditional hormone therapies, as featured in her patented treatment, PearlPAK™, developed by CleopatraRX.

The special featured an all-star panel, including Halle Berry, Naomi Watts, Maria Shriver, Dr. Mary Claire Haver, and comedian Leanne Morgan, who shared personal experiences and underscored the need for open conversations about menopause. Dr. Voskuhl’s contributions highlighted the scientific advancements that empower women to protect their brain health during perimenopause and beyond. “What I love most about being part of this revolution is that it’s women helping women,” she noted, emphasizing the collaborative spirit of the program.

The special is now available for streaming on Hulu and Disney+, offering women worldwide access to this empowering conversation. For more information about Dr. Voskuhl’s work or to learn about PearlPAK™, visit cleopatrarx.com.

🎥 See the message brought to life: Watch the reel on Instagram

Back to Press Room

© Copyright 2025 CleopatraRX™. All Rights Reserved. View our Privacy Policy. and Terms and Conditions.

*PearlPAK™️ dose system is not intended to treat neurological diseases including dementia and Alzheimer’s Disease. It is specifically designed to target cognitive difficulties in perimenopause and early menopausal women only. If you are concerned about neurological disease or have a family history of neurological disease, contact your physician.

CleopatraRX™ and PearlPAK™ are trademarks of CleopatraRX Development, LLC. CleopatraRX™ is a service mark and is used throughout this website to represent the services offered by CleopatraRX Development, LLC. PearlPAK™ is a dosage product for use as a drug/routine system and/or treatment.

The PearlPAK™️ drug/routine system is protected by U.S. Patent No. 10,369,158 – PHARMACEUTICAL PACKAGING FOR ESTRIOL THERAPY – which relates to novel packaged pharmaceutical products for the treatment of neurodegenerative diseases, such as multiple sclerosis, and methods of using these products.

Estriol Therapy U.S. Patent No. 9,962,395 – COMPOSITIONS AND METHODS FOR MAINTAINING COGNITIVE FUNCTION – Provides methods for reducing the progression of cognitive decline in a post-menopausal woman using a continuous regimen of estrogen in combination with periodic administration of a progestogen.

*PearlPAK™ dose system is not intended to treat neurological diseases including dementia and Alzheimer’s Disease. It is specifically designed to target cognitive difficulties in perimenopause and early menopausal women only. If you are concerned about neurological disease or have a family history of neurological disease, contact your physician.

CleopatraRX™ and PearlPAK™ are trademarks of CleopatraRX Development, LLC. CleopatraRX™ is a service mark and used throughout this website to represent the services offered by CleopatraRX Development, LLC. PearlPAK™ is a dosage product is for use as a drug/routine system and/or treatment.

The PearlPAK™ drug/routine system is protected by U.S. Patent No. 10,369,158 – PHARMACEUTICAL PACKAGING FOR ESTRIOL THERAPY – which relates to novel packaged pharmaceutical products for the treatment of neurodegenerative diseases, such as multiple sclerosis, and methods of using these products.

Estriol Therapy U.S. Patent No. 9,962,395 – COMPOSITIONS AND METHODS FOR MAINTAINING COGNITIVE FUNCTION – Provides methods for reducing the progression of cognitive decline in a post – menopausal woman using a continuous regimen of estrogen in combination with periodic administration of a progestogen.